Prevention of Post-Operative Cardiac Arrhythmias

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 870 participants.

Also called NCT04234906

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 870 participants (planned count) (from the registry)
Sponsor
Jeffrey Moak (from the registry)
Registry
  • NCT NCT04234906
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04234906. Randomized; no masking; primary purpose treatment. Start 2023-01 (anticipated); primary completion 2023-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevention of Post-Operative Cardiac Arrhythmias
Acronym
POCA
Condition
Cardiac; Dysrhythmia, Postoperative
Condition
Congenital Heart Surgery
Intervention (Drug)
Dexmedetomidine
Intervention (Drug)
Magnesium Sulfate
Intervention (Drug)
Amiodarone
Intervention (Drug)
Procainamide
Lead sponsor
Jeffrey Moak (class: other)

Record details

Record id
cardio:ct-nct04234906
Content hash
6a4de98f880ca9c9b876d55f39f9eab90febad18f959b029047acadc8b6d94c3